Skip to main content
. 2019 Mar 4;9(1):2045894019832226. doi: 10.1177/2045894019832226

Fig. 2.

Fig. 2.

Barriers to drug repurposing and future directions This figure lists the current barriers to a successful drug repurposing and repositioning including patent, regulatory and organizational hurdles and summarizes future directions and recommendations (modified from Pushpakom et al. Nature Reviews 2018). EU, European Union; US, United States; R&D, Research and Development; NIH-NCATS, National Institute of Health – National Center for Advancing translational Sciences; MRC, Medical Research Council; SPARK, Translational Research Program of Stanford.